SCHEMBL2154372

SCHEMBL2154372

Nc1cccc(CCc2cccc(N)c2)c1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 5/20 0.86
MAOA P21397 5/20 0.86
CYP19A1 P11511 1/20 0.82
CYP3A4 P08684 1/20 0.58
CASP1 P29466 1/20 0.58
RECQL P46063 1/20 0.58
MAPT P10636 2/20 0.51
SIGMAR1 Q99720 2/20 0.50
LMNA P02545 1/20 0.50
HTT P42858 1/20 0.50
RAB9A P51151 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
PARP1 P09874 1/20 0.46
ALDH1A1 P00352 2/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
TDP1 Q9NUW8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29436994 1.00 MAOB (0.86) MAOBMAOACYP19A1CYP3A4CASP1
SCHEMBL3482674 0.95 CYP19A1 (0.91) MAOBMAOACYP19A1CYP3A4CASP1
SCHEMBL4302379 0.93 MAOB (1.00) MAOBMAOACYP19A1CYP3A4CASP1
SCHEMBL1026806 0.90 MAOB (0.71) MAOBMAOACYP19A1CYP3A4CASP1
SCHEMBL18045550 0.90 MAOB (0.71) MAOBMAOACYP19A1CYP3A4CASP1
SCHEMBL29436975 0.90 MAOB (0.71) MAOBMAOACYP19A1CYP3A4CASP1
SCHEMBL29437072 0.90 MAOB (0.71) MAOBMAOACYP19A1CYP3A4CASP1
SCHEMBL28770903 0.87 MAOB (0.68) MAOBMAOACYP19A1CYP3A4CASP1
SCHEMBL30637158 0.87 MAOB (0.68) MAOBMAOACYP19A1CYP3A4CASP1
SCHEMBL30211975 0.87 MAOB (0.68) MAOBMAOACYP19A1CYP3A4CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023286735-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, LIQUID CRYSTAL DISPLAY ELEMENT PRODUCTION METHOD, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2023-01-19 WO claimed
WO-2026100662-A1 LIQUID CRYSTAL ALIGNING AGENT AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2026-05-15 WO disclosed
US-20250382418-A1 DISPLAY PANEL, ALIGNMENT FILM COMPOSITION AND DISPLAY DEVICE Guangzhou China Star Optoelectronics Semiconductor Display Technology Co., Ltd. (CN) 2025-12-18 US disclosed
WO-2025033304-A1 METHOD FOR MANUFACTURING LIQUID CRYSTAL ALIGNMENT FILM, AND METHOD FOR MANUFACTURING LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2025-02-13 WO disclosed
WO-2024058164-A1 LIQUID CRYSTAL ALIGNING AGENT AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2024-03-21 WO disclosed
WO-2023171690-A1 WEAK-ANCHORING LIQUID CRYSTAL ALIGNING AGENT AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2023-09-14 WO disclosed
WO-2023157879-A1 WEAK-ANCHORING LIQUID CRYSTAL ALIGNING AGENT, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2023-08-24 WO disclosed
WO-2023140322-A1 WEAK-ANCHORING LIQUID CRYSTAL ALIGNMENT AGENT, AND LIQUID CYRSTAL DISPLAY ELEMENT 日産化学株式会社 2023-07-27 WO disclosed
WO-2023120726-A1 WEAK-ANCHORING LIQUID CRYSTAL ALIGNMENT AGENT, AND LIQUID CYRSTAL DISPLAY ELEMENT 日産化学株式会社 2023-06-29 WO disclosed
WO-2023048278-A1 WEAKLY ANCHORING LIQUID-CRYSTAL ALIGNMENT AGENT, LIQUID-CRYSTAL DISPLAY ELEMENT, AND POLYMER 日産化学株式会社 2023-03-30 WO disclosed
US-20140221645-A1 Phosphinyl Amidine Compounds, Metal Complexes, Catalyst Systems, and Their Use to Oligomerize or Polymerize Olefins CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2014-08-07 US disclosed
US-8680003-B2 Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2014-03-25 US disclosed
US-20120309965-A1 Phosphinyl Amidine Compounds, Metal Complexes, Catalyst Systems, and Their Use to Oligomerize or Polymerize Olefins CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2012-12-06 US disclosed
EP-2519532-A1 PHOSPHINYL AMIDINE COMPOUNDS, METAL COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OR POLYMERIZE OLEFINS Chevron Phillips Chemical Company LP (US) 2012-11-07 EP disclosed
WO-2011082192-A1 PHOSPHINYL AMIDINE COMPOUNDS, METAL COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OR POLYMERIZE OLEFINS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2011-07-07 WO disclosed
EP-0390992-B1 Aromatic polyimide double layered hollow filamentary membrane and process for producing same UBE INDUSTRIES (JP) 1994-06-01 EP disclosed
US-5141642-A Separators for reverse osmosis, ultrafiltration, dehydration, heat and chemical resistance, strength, gas permeability UBE INDUSTRIES, LTD. (JP) 1992-08-25 US disclosed
US-4377652-A PARTICLES DISPERSED IN A POLYMER BASED ON AN AROMATIC DIAMINE AND TRIMELLITIC ACID OR DERIVATIVE; DIELECTRICS; SUBSTRATES; PRINTED CIRCUITS ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1983-03-22 US disclosed
US-4316974-A POLYAMIDEIMIDE COPOLYMERS ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1982-02-23 US disclosed
US-4208477-A POLYAMIDEIMIDE COPOLYMER ENDCAPPED WITH ACRYLIC GROUPS, PHOTOINITIATOR, ETHYLENICALLY UNSATURATED COMPOUND ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1980-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120309965-A1 Phosphinyl Amidine Compounds, Metal Complexes, Catalyst Systems, and Their Use to Oligomerize or Polymerize Olefins NIT2, NCLN, NPM1 MAOB 2884/4885MAOA 3125/4885CYP19A1 4815/4885
US-20140221645-A1 Phosphinyl Amidine Compounds, Metal Complexes, Catalyst Systems, and Their Use to Oligomerize or Polymerize Olefins NIT2, NCLN, NPM1 MAOB 2884/4885MAOA 3125/4885CYP19A1 4815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.